Apontis Pharma AG (APPH) — Capital Reinvestment Ratio
Apontis Pharma AG (APPH) has a Capital Reinvestment Ratio of 0.01x as of December 2024, meaning it reinvests 0% of its operating cash flow (€905.24K) in capital expenditures (€5.60K). See net asset quality index of Apontis Pharma AG to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Apontis Pharma AG Capital Reinvestment Ratio (2020–2022)
This chart tracks Apontis Pharma AG's Capital Reinvestment Ratio across 3 annual periods. Check APPH capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Apontis Pharma AG (2020–2022)
Year-by-year Capital Reinvestment Ratio for Apontis Pharma AG from 2020 to 2022. For live market cap and broader valuation context, see Apontis Pharma AG market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.30x | €11.02 Million | €3.28 Million | ▼ -38.5% |
| 2021 | 0.48x | €3.43 Million | €1.66 Million | ▼ -3.8% |
| 2020 | 0.50x | €1.45 Million | €729.56K | — |